提示良性前列腺增生的下尿路症状的管理：患者风险概况的核心作用。 - Suppr

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.

作者信息

Crawford E David

机构信息

University of Colorado Health Sciences Center, Aurora, Colorado 80010, USA.

出版信息

BJU Int. 2005 Jun;95 Suppl 4:1-5. doi: 10.1111/j.1464-410X.2005.05484.x.

DOI:10.1111/j.1464-410X.2005.05484.x

PMID:15871729

Abstract

摘要

相似文献

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.

BJU Int. 2005 Jun;95 Suppl 4:1-5. doi: 10.1111/j.1464-410X.2005.05484.x.

Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.

Urology. 2004 Mar;63(3):428-34. doi: 10.1016/j.urology.2003.09.063.

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.

BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x.

Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.

Curr Opin Urol. 2006 Jan;16(1):11-9.

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.

BJU Int. 2005 Jun;95 Suppl 4:6-11. doi: 10.1111/j.1464-410X.2005.05488.x.

[The objective of medical treatment: relieve the symptoms or stop the course?].

Ann Urol (Paris). 2006 Mar;40 Spec No 1:14-6.

Medical management of lower urinary tract symptoms in men: current treatment and future approaches.

Nat Clin Pract Urol. 2008 Apr;5(4):211-9. doi: 10.1038/ncpuro1060. Epub 2008 Feb 26.

Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.

Int J Impot Res. 2007 Jul-Aug;19(4):386-92. doi: 10.1038/sj.ijir.3901540. Epub 2007 Mar 22.

Breakthrough treatment for prostate enlargement.

Johns Hopkins Med Lett Health After 50. 2003 Apr;15(2):3, 7.

[Medical therapy of benign prostatic hyperplasia].

Lijec Vjesn. 2005 Nov-Dec;127(11-12):316-23.

引用本文的文献

A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.

Med Sci Monit. 2016 Jun 4;22:1895-902. doi: 10.12659/msm.896283.

Treatment of benign prostatic hyperplasia in patients with cardiovascular disease.

Drugs Aging. 2006;23(10):795-805. doi: 10.2165/00002512-200623100-00003.

Benign prostatic hyperplasia: treatment in primary care.

BMJ. 2006 Sep 9;333(7567):535-9. doi: 10.1136/bmj.38946.616551.BE1.

Acute urinary retention: who is at risk and how best to manage it?

Curr Urol Rep. 2006 Jul;7(4):252-9. doi: 10.1007/s11934-996-0003-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.

作者信息

机构信息

出版信息

相似文献

引用本文的文献